Navigation Links
InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group
Date:4/28/2008

Blood Pressure-Lowering Device to be Available at 1,440 Stores in May 2008

NEW YORK and LONDON, April 28 /PRNewswire/ -- InterCure Ltd., a medical device company publicly traded on the Tel Aviv Stock Exchange (TASE: INCR), today announced that its RESPeRATE(R) hypertension treatment device, clinically-proven to significantly lower blood pressure, will launch into full-scale retail distribution within the United Kingdom this May through Lloyds Pharmacy, the leading community pharmacy chain in the UK.

Per the distribution agreement, Lloyds Pharmacy will distribute RESPeRATE in 1,440 stores beginning in May 2008 and for a limited period will be the only nation-wide UK retail chain to carry the product. As part of the launch, RESPeRATE, retailing at 199 pounds Sterling, will be prominently displayed as part of Lloyds in store merchandising programmes. This prime position will allow consumers to learn more about RESPeRATE and interact with the device. Lloyds Pharmacy will also offer product demonstrations to instruct consumers how to successfully include RESPeRATE into their overall hypertension management regimen.

"With many of our shoppers looking for new ways to manage hypertension with a treatment that fits into their lifestyles, we are pleased to offer RESPeRATE as a complement to our existing line of innovative healthcare products and services," said Justin Woodward, senior marketing manager at Lloyds Pharmacy.

"The full-chain launch of RESPeRATE at Lloyds Pharmacy clearly demonstrates the broad appeal of our effective and truly natural device-guided breathing therapy for hypertension," said Erez Gavish, president and CEO of InterCure. "Commanding a premium 199 pounds price point at this respected retailer is yet another validation of the value of RESPeRATE in the management of high blood pressure. Lloyds Pharmacy has built a strong reputation by educating consumers and providing them with innovative healthcare products that meet the
'/>"/>

SOURCE InterCure Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. InterCure Names Scot Dube Vice President of Sales
2. InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia
3. SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
4. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
5. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Piedmont Pharmaceuticals Secures $8.5 Million Investment
8. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
9. UI licensee Optherion secures $37 million in financing
10. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
11. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 Dr. Alex Rabinovich and ... announce expanded offerings for Bay Area patients considering dental ... Center has long been a top-rated center, serving primarily ... to meet the strong demand by others throughout Northern ... a top-rated dental implant facility in San Francisco,”explained Dr. ...
(Date:3/26/2015)... March 26, 2015 Pacific Medical LLC, ... pleased to be featured on Innovations with Ed Begley ... 18, 2015. The episode will repeat on local ... on the Pacific Medical home page at: http://www.pacificmedicalsupply.com ... emergencies, it is reassuring to trust the integrity of ...
(Date:3/26/2015)... Altamonte Springs, FL (PRWEB) March 26, 2015 ... one of the nation’s leading innovative specialty pharmacies, ... newly created position of Vice President of Pharmaceutical ... for fostering beneficial connections with our pharmaceuticals partners ... pharmaceutical relationships in support of BioPlus’ expansion. ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... for Assessment and Evaluation , has announced its ... enable institutions, organizations, and corporations to accurately and ... successful learning. , Utilizing Questionmark’s state-of-the-art software ... will offer improved delivery of the seventy-five ...
(Date:3/26/2015)... In the key developed markets, the hypertension ... is set to decrease through 2020 at a negative CAGR ... expected up to 2017 at a 2.6% CAGR and a ... to the surging penetration of fixed-dose combination drugs like Azor, ... Benicar HCT, and Tekamlo), a hike in the prevalence population ...
Breaking Medicine News(10 mins):Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3
... repeat problems seen in 1976 episode , TUESDAY, July ... in 1976 to vaccinate 43 million people against swine ... the dreaded outbreak never materialize (illness never spread beyond ... 500 Americans who did get vaccinated came down with ...
... , Innovative child welfare practices from across ... , , SEATTLE, July 21 ... way they do business. These changes are improving the lives of children ... care. , , (Logo: ...
... AlphaRx plans to open an R&D facility and manufacturing plant ... innovative drug products to the fastest, growing ... July 21 /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX - News), an ... novel formulations of drugs, is forging ahead with its growth ...
... , , Clinical ... inspections , , Washington, ... the same safety, ethical and quality standards as those conducted in ... report released today by the Association of Clinical Research Organizations (ACRO). ...
... , , BALTIMORE, July 21 ... to people that want to take control of their health, and ... to employers announced that they have reached an agreement to bring ... their employees - "stay healthy." , , ...
... , SCOTTSDALE, Ariz., July 21 ... in their personal expenses. No longer are trendy fashion statements considered ... into aesthetic treatments aimed at improving or enhancing appearance, and those ... , Suggestions to make the most of your beauty ...
Cached Medicine News:Health News:Safety of Swine Flu Vaccine to Face Tough Scrutiny 2Health News:Safety of Swine Flu Vaccine to Face Tough Scrutiny 3Health News:Safety of Swine Flu Vaccine to Face Tough Scrutiny 4Health News:New Report Sets a Course for Improving Foster Care Systems 2Health News:New Report Sets a Course for Improving Foster Care Systems 3Health News:AlphaRx Unveils its China Strategy 2Health News:Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says 2Health News:Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says 3Health News:Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says 4Health News:Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says 5Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 2Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 3Health News:The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget 2Health News:The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget 3
(Date:3/26/2015)... March 26, 2015  Oxis Biotech, Inc. ... International, Inc. [OTC: OXIS] and [Euronext Paris: ... exclusive option agreement with the University of ... by Dr. Xiang-Qun Xie , Associate ... Sciences, School of Pharmacy.  These patents/intellectual properties ...
(Date:3/26/2015)... BUENA, N.J. , March 26, 2015 ... New Jersey based specialty generic pharmaceutical company, ... drug application (ANDA) to the U.S. Food and Drug ... number of ANDA submissions now pending at the FDA ... and CEO of the Company, commented, "On March 2, ...
(Date:3/26/2015)... , March 26, 2015  CNBC profiled MJ Freeway ... part of a series "How I Did It," which features ... the High Road" released yesterday, illustrates how two tech ... leading IT providers to the marijuana industry. ... describes how Co-Founders Amy Poinsett and Jessica Billingsley ...
Breaking Medicine Technology:Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2MJ Freeway, Industry-Leading Software Solution for Cannabis Businesses, Featured in CNBC Special "How I Did It" 2
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Sodium in serum and plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: